JEROD MCKEEHAN: Open Payments
NPI 1285286609 · MAGNOLIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 54 payments from 14 companies in 2025. Trend: 2023 $1,852 · 2024 $1,781 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $344 |
| AstraZeneca Pharmaceuticals LP | 5 | $136 |
| Novo Nordisk Inc | 3 | $77 |
| PFIZER INC. | 2 | $51 |
| Exact Sciences Corporation | 2 | $47 |
| Amgen Inc. | 2 | $39 |
| Medtronic, Inc. | 2 | $37 |
| Antares Pharma, Inc. | 2 | $36 |
| TOLMAR, INC. | 2 | $36 |
| Dexcom, Inc. | 1 | $25 |
Products named: QULIPTA, FARXIGA, VRAYLAR, UBRELVY, NURTEC ODT, Cologuard Collection Kit, OTEZLA, INCEPTIV.
Industry payments across TX — which companies pay providers there.
